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Mission 
To improve health through
research and information
In 2003 the Health Research Board continued to deliver
successful results in line with the objectives set out in the
Corporate Strategy 2002–2006:
■ To encourage the creation and application of knowledge for health and social gain, the growth of
intellectual property and evidence relevant to health and social gain and the emergence of a
knowledge-based health system, economy and society
■ To be the lead national organisation in relation to support for scientific research for health and
social gain, including basic and translational research, health services research, population health
and practice-based research
■ To promote the growth of a value-added research and development capability in the health
system, in partnership with other relevant health organisations
■ To impact on health and social policy and services through high-quality research and information
■ To be the main advocate for the development of research for health and social gain
■ To make the HRB an employer of choice in its field
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Chairman’s Statement
I was delighted and honoured to be elected Chair of the Health Research Board in the autumn of
2003. The achievements of the Board in 2003 are mainly those of my predecessor, Hugh Brady, then
Professor of Medicine and Therapeutics at University College Dublin, who was appointed President of
UCD, commencing in 2004. His pivotal role in the development of biomedical research in Ireland, as
a clinician scientist, leader and innovator, was reflected in the impact he had on the restructuring of
the HRB and the way he drove the corporate strategy.
Against a backdrop of major change in the sector during 2003, the HRB delivered a variety of new
initiatives and continued to innovate in core programmes to deliver positive results. 
■ Two academic institutions were selected for funding as PhD training sites. These awards will help
to develop a structured post-graduate degree programme centred round a group of investigators
working on a common theme. This investment of €2 million over four years will improve the
quality and effectiveness of training for 14 young researchers at a critical stage in their careers.
■ The Board welcomed the capital award of €4.5 million which helped to fund a number of
competitive calls for research equipment to support translational and paediatric research and
awards for health information systems to underpin health policy and health services.
■ Considerable preparation was made for the introduction of clinician scientist awards in 2004.
This innovative scheme will give clinicians protected time and resources to focus on research.
■ Major steps were taken to encourage health agencies to undertake research to achieve the
objectives of the national health strategy, Quality and Fairness – A Health System for You (2001).
Proposals for strategic research and development awards were created, with a view to
advertising the scheme in 2004.
■ Vital data and research from the national health information systems, managed by the HRB,
underpinned national planning and distribution of services in relation to drug misuse, disability
and mental health. The improved quality of the information and analysis from these databases
has been crucial in supporting policy during 2003. The ongoing value of these high-quality
systems is dependent on information from health workers throughout the country. It is essential
that the data-collection mechanisms that are used remain and are enhanced through health
service reform.
Ongoing work with the R&D Office in Belfast facilitated all-Ireland health research and collaboration. 
In addition to participation in the Ireland–Northern Ireland–National Cancer Institute Cancer
Consortium during the year, a feasibility study was commissioned on the development of an all-
Ireland Gene Library. The aim is to provide a resource to support research into the genetic factors
underlying diseases such as diabetes, arthritis, depression and prostate cancer. 
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In November 2001, the Department of Health and Children published Making Knowledge Work for
Health – A Strategy for Health Research. This strategy aims to develop a strong research culture within
the health system. It clearly outlines an approach to building health research capacity that will underpin
quality and effectiveness in the health system as part of the Government’s wider commitment to
research for future economic and social development. 
During 2003, the HRB endeavoured through the work programme to ensure this strategy was
realised in the context of the newly restructured and reformed health service. However, many of the
objectives of Making Knowledge Work for Health, which were endorsed in the National Health
Strategy, have yet to be delivered. 
The transformation of the entire health sector in 2003 created a unique opportunity to instil a
research culture at a crucial stage of its evolution. This was further emphasised by the Prospectus
Report 2003 on the audit of structures and functions of the health system, which identified the critical
function that research plays in the healthcare system by:
■ Enabling informed decisions supported by a strong evidence base
■ Providing an impetus for innovation in the operation of the health service 
■ Helping to attract and retain the highest calibre staff
The need for a strong research infrastructure in the health system is recognised in the
complementary funding of research by other state agencies and research charities. The HRB
continued to integrate its activities with other funding bodies for maximum impact in delivering the
objectives. A key part of this was participation in the Merrion Group, which was initially chaired by the
Chief Executive of the HRB. Key results of this group included: 
■ A common approach to intellectual property arising from funded research
■ A streamlining of application and award procedures
■ Agreement on performance indicators
■ Better co-ordination of agency activities
I would like to thank the staff of the HRB for their hard work, commitment and compliance with the
principles of professionalism, excellence and efficiency, a culture that is evident throughout the organisation.
The work of my colleagues on the Board must also be acknowledged. They are involved in an
increasing number of sub-committees due to the increased activity of the HRB and the need for greater
transparency. I appreciate their expertise, advice and persistence in the effort to deliver the HRB
strategy and realise the aims of Making Knowledge Work for Health – A Strategy for Health Research.
Professor Desmond Fitzgerald MD MRCPI
Chairman of the Board
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Chief Executive’s Report 
The major changes proposed in the health services in 2003 emphasised the need for the HRB to
invigorate the health research agenda with renewed strength and vision. It was encouraging that the
importance of health research, and the role of the HRB in supporting that research, was recognised
in the Prospectus Report. It is also clear that the role of the proposed Health Information and Quality
Authority will be complementary to that of the HRB and there is much scope for co-operation in the
interests of building better information for health when the new authority is fully established.
In spite of this endorsement, the opportunities presented by health service reform to implement the
commitments of the research strategy, Making Knowledge Work for Health, have not been prioritised.
The HRB believes that this must happen if the objectives of the Corporate Strategy – to encourage
the creation and application of knowledge for health and the growth of research and development
capability – are to be achieved. In 2003, progress on implementing these key commitments was
disappointing. 
To date, the opportunity presented by the health reform programme to appoint a Director of R&D for
Health to the Department of Health and Children and establish the Health Research Forum,
commitments of Making Knowledge Work for Health, has not been taken. The HRB made
submissions on the health reform programme and continues to support these submissions and the
implementation of the EU Clinical Trials Directive, which indicated the urgent need to appoint a
Director to provide national leadership on the research and development for health agenda. 
It is encouraging that a former chair and a current HRB board member were appointed to the board
of the Health Services Executive (HSE). It will be vital that the HSE takes responsibility for
implementing the research and development commitments involving the health boards, as outlined in
Making Knowledge Work for Health, which include the appointment of R&D officers and the
preparation of health research strategies.
In the context of major change and challenge, the HRB made considerable progress on a number of
fronts. Many of these are referred to in the Chairman’s statement. 
The appointment of clinician scientists has been a priority of the HRB for a number of years. During
2003, the HRB engaged in discussions with the Department of Health and Children and the medical
representative organisations to gain their agreement on changes to the academic consultant contract to
facilitate the creation of posts of clinician scientist. The HRB brought the issue as far as it could and it is
hoped that formal negotiations will begin in 2004 between health management and the medical
organisations on amendments to the consultant contract to facilitate these important appointments.
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The HRB was pleased to publish A Picture of Health, which summarises in an accessible way the
research funded by the HRB in 2002. This publication was well received and will be published on an
annual basis. 
A highlight of the year was the renewal of a major contract for research involving the HRB on the
aetiology of neural tube defects, awarded by the National Institutes of Health in the United States. 
During 2003 the role of the Research and Development for Health division developed. A milestone
was the publication of a report, commissioned by the Department of the Environment and Local
Government, entitled Health and Environmental Effects of Landfilling and Incineration of Waste. The
division also had an important role in supporting the all-island cancer clinical trials initiative on behalf
of the Ireland–Northern Ireland–National Cancer Institute Cancer Consortium.
Significant improvements were made to the databases managed by the HRB, particularly the National
Psychiatric In-patient Reporting System and the National Drug Treatment Reporting System. Web-
based technology was used for the first time to support the development of a National Physical and
Sensory Disability Database. The resources of the National Documentation Centre on Drug Use were
used by a growing number of clients in 2003. 
Much attention was also given to improving the HRB’s internal processes to increase effectiveness and
to achieve the objective of the Corporate Strategy to make the HRB an employer of choice in its field.
An internal audit system was introduced and risk management was formalised. A comprehensive
programme of human resource development was initiated, including the introduction of a performance
management system. The HRB media profile was strengthened as a result of a more focused approach
to communicating the importance of health research and the role of the HRB.
Promoting health research and the role of the HRB in the national system of science, technology and
innovation on the island of Ireland, and in collaboration with international partners, is an important
part of ensuring the achievement of the HRB’s corporate objective to be the lead national
organisation in relation to support for scientific research for health. Excellent working relationships
with other research-funding bodies were maintained and participation continued in all-island, inter-
agency, inter-departmental and EU-based bodies to develop the national research agenda and the
contribution of health research in achieving that agenda. 
I would like to thank Professor Hugh Brady for his outstanding leadership of the HRB in 2002/3 and
for his contribution as a member of the Board since 1997. We wish him every success in his role as
President of University College Dublin. I would like to thank Professor Desmond Fitzgerald for his
guidance and support, both as a member of the Board and as Chairman in the latter half of the year.
The dedicated work of the staff has been outstanding and their commitment is reflected in the
achievements reported here. I appreciate their ongoing innovation and drive to meet the corporate
objectives of the HRB and to deliver a quality service to all our stakeholders.
Ruth Barrington PhD
Chief Executive
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Research Funding and Policy 
Research Funding and Policy had a successful year, with a
variety of achievements and preparation for a number of
new initiatives, which included:
■ Processing 788 applications for funding and making 196 awards
■ Developing clinician scientist awards
■ Launching A Picture of Health, a publication that summarises in simple terms the key findings 
of selected health research projects funded by the HRB in 2002
■ Reviewing and extending the online application system to most funding programmes
Research awards
The HRB made 196 awards from 788 applications for funding as part of its ‘science for health’
activities. A total of 86 research awards were made across 12 schemes; an additional 110 awards
were made through the summer students’ scheme and science writing workshops. Evaluating the
applications involved 23 committees and more than 600 international reviewers. The total value of
awards made was approximately €12 million.
Awards included grants for projects, programmes, fellowships and workshops. The areas covered
basic and translational research, health services research, population health and practice-based
research. Excluding the science writing workshops and summer student scheme, there were 512
applications for research grants and 86 awards were made. This translated into an average success
rate of 17 per cent across all funding schemes, making it a particularly competitive year. A full list of
awards is given in the Appendix. 
A sum of €3.5 million was secured to fund awards for infrastructure and equipment in health
research; 62 applications were received and 23 awards made. This call was run jointly with Research
and Development for Health. 
In addition to awards made through existing fellowship schemes, three fellowships were awarded
through a new scheme aimed at professionals working in primary care. The research is expected to
underpin the primary care strategy launched by the government in 2001.
A series of science writing workshops was run in conjunction with the British Council. These aim to
help researchers in the early stages of their careers to improve their writing skills. The workshops
address effective communication of research findings, currently a major deficit in research training. In
response to very positive feedback from evaluation forms, the workshops will be run again in 2004.
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Work continued on the development of clinician scientist fellowships for medical doctors, in
collaboration with Science Foundation Ireland. A number of key meetings were held with medical
organisations to canvass support for the fellowships.
Online applications 
The division continued to develop IT systems to improve the efficiency of processes and support the
developing evaluation function. Following a review of the eGrants system, the online applications
system was extended so that applications to all schemes (with the exception of nursing and
midwifery fellowships) were made online.
The grants database was upgraded to facilitate downloading information from the online applications
to the database. Working with the Finance team, the division made changes to ensure the accuracy
of database information for payment of grants.
Evaluation
Considerable progress was made in developing the research evaluation function. For the first time, a
selection of research funded by the HRB was published. A Picture of Health – A selection of Irish
Health Research brought together the findings of HRB-funded research projects and fellowships
completed in 2002 in a way that was accessible to a lay audience. The report attracted a lot of
interest and will be published annually in the future.
A full evaluation of the general project grants scheme was launched to ensure that it was meeting its
objectives. This is due for completion in 2004 and the findings will inform the re-organisation of the
scheme and its related committees in 2004. 
A review of the Health Gain and Health Status Unit in UCD was carried out, and approval given to
fund the final year of this programme. 
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Building capacity
As part of its role in supporting the strategic development of health research in Ireland, the division
was represented on the following working groups and review panels:
■ Irish Council for Science, Technology and Innovation taskforce on nanotechnology and
‘European Research Area 3 per cent’ working groups established by Forfás (Public Funding and
Framework Conditions)
■ European Medical Research Council (EMRC) Standing Committee of the European Science
Foundation
■ Standing Committee of Research Funding Agencies
■ Ad hoc group of European Nurse Research Developers
Research Funding and Policy also continued to work with other funding agencies to develop a
consistent approach to intellectual property for publicly funded research. Changes in policy were
incorporated into the HRB Grant Regulations. The division was also pleased to participate in the
strategic review panel for Science Foundation Ireland’s Centres for Science, Engineering and
Technology (C-SET) applications in biotechnology.
The opportunity to develop national and European research networks continued, with membership
of, and participation in:
■ EMRC Standing Committee of the European Science Foundation
■ Irish Evaluation Network
■ Irish Society of Clinical Research Professionals
■ Irish Internet Association
The division also supported a number of successful events: 
■ The Watts Medal for 2003 was won by Aileen Byrne, a final year science student in UCD, for her
project, ‘Effects of the vascular endothelial growth factor family and endostatin on blood retinal
barrier function’. 
■ The 43rd Graves Lecture was delivered by Dr Leonie Young, Lecturer in Surgery at University
College Dublin. The title of Dr Young’s lecture was ‘Transcriptional Regulation in Human Breast
Cancer’. The Graves Medal for 2003 was awarded to Dr Young following her lecture.
■ The JMS Doctor Awards aim to honour achievements in clinical research; it was particularly
encouraging that a number of awards were won for HRB-funded research. 
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Award Schemes Applicants Awards
Career Support Schemes
Post-Doctoral Fellowships 31 3
Clinical Research Training Fellowships 38 3
Fellowships in Health Services Research 21 3
Clinical Research Fellowships in Nursing and Midwifery 17 4
Primary Care Research Fellowships 15 3
Project Grants
Project Grants – General 259 33
Project Grants – North–South Co-operation 20 4
Project Grants – Inter-Disciplinary 24 2
Project Grants – Co-funded in Health Services Research 9 3
Blood Utilisation / Hepatitis C
Programme Grants 2 2
Project Grants 14 3
Capital / Equipment 40 17
TOTAL (research awards) 512 86
Other Support
Summer Students 106 30
HRB / British Council Science Writing Workshops 170 80 (workshop places)
TOTAL (all awards) 788 196
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One year after the establishment of this division, there has
been substantial progress in fostering a strong R&D culture
within the health services. Key areas of progress include: 
■ Promotion of R&D for health in health agencies and the Department of Health and Children
■ Introduction of a new infrastructure award
■ Completion of a proposal for lottery funding to support health research in collaboration with
health research charities
■ Ongoing co-ordination of national free access to the Cochrane Library
■ Active involvement in the Ireland–Northern Ireland–National Cancer Institute (NCI) Cancer
Consortium 
R&D for Health
Developing a strong R&D culture and function within the health services was a pivotal part of the
national health strategy, Making Knowledge Work for Health. The strategy highlighted the contribution
that R&D could make to efficient and high-quality health polices and interventions. During 2002 this
was achieved through the promotion of R&D at health agency and departmental level, capacity
building initiatives, partnership working with other health agencies and provision of research funding
and policy advice. 
The HRB actively liaised with the chief executives of health boards and other health agencies to
encourage the appointment of R&D Officers to facilitate regional growth of R&D for health. Agreement
was reached nationally on the nature and details of these posts and funding was identified; however,
no appointments were made to these posts in 2003.
Ongoing efforts were made to promote the appointment of a Director of R&D within the Department
of Health and Children to drive a strong health research agenda at a national level in line with the
need identified in the national health research strategy. 
Research policy and guidance
Key roles in this area included:
■ Co-ordinating the submission of a paper on cancer research to the National Cancer Forum for
the soon-to-be-published National Cancer Strategy. This was prepared in consultation with
members of the Ireland–Northern Ireland–NCI Cancer Consortium working groups.
■ Making a submission to the Department of Health and Children on the potential implications of
the EU Clinical Trials Directive for investigator-led research on the island of Ireland. The
submission was prepared following discussions with researchers across the island, drawing on
HRB experience in funding the All-Ireland Cooperative Group for Cancer Clinical Trials.
Commissioned research
R&D for Health has a mandate to commission research on health issues on behalf of other agencies.
During 2003, activity in this area included:
■ Health and Environmental Effects of Landfilling and Incineration of Waste – A Literature Review,
commissioned by the Department of the Environment and Local Government. This report was
launched during the year and aims to inform the debate by policy makers on this contentious issue. 
■ Initial work on commissioning a report on Nursing Research Priorities, to be funded by the
Council for the Professional Development of Nursing and Midwifery.
The Cochrane Library
R&D for Health continued to promote the translation of research into evidence for decision making,
by co-ordinating national free access to the Cochrane Library of systematic reviews, in association
with the R&D Office in Belfast. Related activities in 2003 included:
■ Building on the free provision of the database, the HRB co-organised a series of training courses
on ‘systematic review’, ‘writing a protocol’ and ‘meta analysis’ with the R&D Office in Belfast.
These training courses aimed to increase participants’ ability to use the Library and to conduct
systematic reviews. The courses were very successful and attracted participants from various
health disciplines in Ireland. 
■ Four new Cochrane Fellowships were awarded in 2003 to allow protected time for fellows to
conduct a systematic review for submission to the Cochrane Library. 
Infrastructure awards
A new capital investment scheme was introduced for infrastructure to support the development of
research information systems relevant to the health services. A total of 21 applications were received
and six awards were made, valued at €1.2m.
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Networking and capacity building
As R&D in the health services is a new concept in Ireland, the opportunity to build capacity within 
the system and develop new links, nationally and internationally, is of tremendous benefit. R&D for
Health embraced this opportunity in a number of ways, particularly in its association with the
Ireland–Northern Ireland–NCI Cancer Consortium. Key activities included:
■ The award of a €1 million planning grant over two years to the new All-Ireland Cooperative Group
for Cancer Clinical Trials (made up of the Irish Clinical Oncology Research Group in Dublin and the
Clinical Research and Support Centre in Belfast). This new Group will support the existing network
of nine hospitals funded by the HRB and the hospitals funded by the R&D Office in Belfast, to help
them achieve their objective of increased capacity to conduct cancer clinical trials consistent with
the priorities on the island. A consultant was engaged jointly by the HRB and the R&D Office to
work with the Group towards attaining its objectives in the planning phase.
■ A second Cancer Epidemiology Fellowship was awarded by the HRB for a three-year fellowship
in the NCI (US).
■ Twenty-two participants sponsored by the HRB attended the (NCI) Summer Curriculum in
Cancer Prevention. 
■ Two nurses attended a six-week programme on cancer clinical trials at the NCI in October.
■ The Prevention Working Group of the Consortium hosted the first in a series of workshops, this
one focusing on smoking cessation, that resulted in information exchange between participants
and a series of research recommendations on this topic. 
■ The Cancer Consortium hosted a showcase conference in Cork in October, with key national
and international speakers on topics ranging from prevention to therapeutic developments to
survivorship and quality of life.
The division represented Ireland on a European pilot programme, ‘European and Developing
Countries Clinical Trials Partnership (EDCTP)’, initiated in late 2003. The pilot was aimed at
accelerating the development of new clinical interventions to fight HIV/AIDS, malaria and TB in
developing countries. In collaboration with Development Cooperation Ireland, the HRB created links
between this initiative and Ireland’s National Programme of Funding into the three disease areas.
Strong relations were maintained with the Association of Research Charities and a proposal was jointly
submitted to the Department of Health and Children to secure lottery money to support health
research. The division will provide research management support to charities when funding is secured.
Other examples of capacity-building initiatives by the R&D division in 2003 include:
■ A two-day workshop on the Principles of Research Ethics, provided by the Centre for
Professional Ethics at Keele University, UK.
■ Co-funding a team from the Institute of Public Health in Ireland and Best Health for Children to
conduct a review on adolescent para-suicide, one of a series of health reviews completed under
the UK and Ireland Public Health Evidence group. This team was also trained to conduct
systematic reviews.
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Child Health Epidemiology Research
This division had a busy and challenging year, which centred
on established research programmes on the aetiology and
prevention of neural tube defects, orofacial clefts and other
congenital malformations. Highlights included: 
■ Receiving top marks from peer reviewers and securing US$4.3 million to continue and expand the
collaborative research programme on congenital malformation and other adverse pregnancy outcomes
■ Exceeding recruitment and participation targets in two research programmes
Research programme progress
Research on the aetiology and prevention of neural tube defects (NTDs), orofacial clefts and other
congenital malformations continued in collaboration with the National Institute of Child Health and
Human Development (NICHD) and Trinity College Dublin (TCD). This study is funded by the NICHD,
part of the National Institutes of Health in the United States.
All NTD recruitment and follow-up was completed with participating families by December. The 2003
recruitment target of 100 families was exceeded by 10 per cent, with 62 families in Ireland, 22 in
Northern Ireland and 26 in England and Wales. Since this project commenced in 1992, a total of 553
families have been recruited from Ireland, 134 from Northern Ireland and 395 from England and Wales.
Recruitment of persons affected by orofacial cleft continued through cleft clinics held at Our Lady’s
Hospital for Sick Children, Crumlin, the Children’s Hospital Temple Street, St James’s Hospital and
Sligo General Hospital. The target recruitment figure for 2003 was 200 families and 282 families were
successfully recruited.
The research team continued to liaise with branches of the Cleft Lip and Palate Association of Ireland
(CLAPAI). At the end of 2003, a total of 173 families had been recruited through CLAPAI.
A key focus during the year was on data analysis and writing up the results for all of the studies
being carried out under the NICHD contract. 
A bid for contract renewal from the NICHD for a further three-year period was successful. This will
facilitate the expansion of our collaborative research programme on congenital malformations and
other adverse pregnancy outcomes. The proposal was awarded a very high mark by the peer
reviewers and a contract valued at US$4.3 million was signed. This funding will enable a further eight
research staff to be appointed to the team. 
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A key objective of the division is to develop an epidemiological research programme in child health,
with particular reference to Irish children and focusing initially on four specific topics: the effectiveness
of public health programmes to prevent NTDs using folic acid, investigating social class differences in
infant and child mortality, child injury, and monitoring the major statistical indicators of child health. 
Preliminary discussions with individuals working in the child health area (for example, the  Programme
of Action for Children run by the Health Boards Executive, the National Children’s Office, the Institute
of Public Health in Ireland, the Public Health Departments of the health boards) have helped to clarify
the priorities of the proposed research programme. 
Networking and capacity building
When research involves and impacts on people, the value of networking and capacity building cannot
be underestimated. Frequent contact was maintained with the Irish Association for Spina Bifida and
Hydrocephalus, public health nurses, the Central Remedial Clinic, the Northern Ireland Association for
Spina Bifida and Hydrocephalus, the UK Association for Spina Bifida and Hydrocephalus, the
Scottish Association for Spina Bifida and Hydrocephalus, the Dublin Cleft Centre and the Cleft Lip
and Palate Association of Ireland.
Members of the division also attended the AGM of the Association for Spina Bifida and
Hydrocephalus (Ireland) and regional meetings of public health nurses.
To underpin the work programme, revisions were made to the manuals of operation for the Irish
Genetic Study of NTDs and the Irish Genetic Study of Orofacial Clefts. Protocols and guidelines for
data checking, data analysis, anonymisation, and inclusion and exclusion criteria were also reviewed
and amended.
Publications
Publication of research findings in top international medical scientific journals is the key output
measure of the research programme. During the year, five research papers were submitted for
publication:  three have been published and two are under consideration.
O’Leary VB, Mills JL, Kirke PN, Parle-McDermott A, Swanson DA, Weiler A, Pangilinan F, Conley M,
Molloy AM, Lynch M, Cox C, Scott JM and Brody LC (2003) Analysis of the human folate receptor ß
gene for an association with neural tube defects. Molecular Genetics and Metabolism, 79: 129–133.
Parle-McDermott A, Mills JL, Kirke PN, O’Leary VB, Swanson DA, Pangilinan F, Conley M, Molloy
AM, Cox C, Scott JM and Brody LC (2003) Analysis of the MTHFR 1298A → C and 677 → T
polymorphisms as risk factors for neural tube defects. Journal of Human Genetics, 48: 190–193.
Parle-McDermott A, McManus EJ, Mills JL, O’Leary VB, Pangilinan F, Cox C, Weiler A, Molloy AM,
Conley M, Watson D, Scott JM, Brody LC and Kirke PN (2003) Polymorphisms within the vitamin
B12 dependent methylmalonyl-coA mutase are not risk factors for neural tube defects. Molecular
Genetics and Metabolism, 80: 463–468. 
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Kirke PN, Mills JL, Molloy AM, Brody LC, O’Leary VB, Daly L, Murray S, Conley C, Mayne PD, Smith
O and Scott JM (2003) A single polymorphism (MTHFR C677T) puts half of the population at
increased risk of neural tube defects: case-control study. Submitted for publication.
Parle-McDermott A, Mills JM, Kirke PN, Cox C, Signore CC, Kirke S, Molloy A, O’Leary VB,
Pangilinan FJ, O’Herlihy C, Brody LS and Scott JM (2003) The MTHFD1 R653Q polymorphism is a
maternal genetic risk factor for severe abruptio placentae. Submitted for publication.
Kirke PN and McKeever MP (2003) Update on the genetic study of spina bifida and other neural tube
defects. LINK – the magazine of the UK Association for Spina Bifida and Hydrocephalus, January.
Kirke PN and McKeever MP (2003) Update on the genetic study of spina bifida and other neural tube
defects. LINK –  the magazine of the UK Association for Spina Bifida and Hydrocephalus, June.
Research presentations
■ Kirke PN, Mills JL, Molloy AM, Brody LC, O’Leary VB, Parle-McDermott A, Daly L, Murray S,
Mayne PD, Smith O, Cox C and Scott JM (2003) Increased risk of neural tube defects
associated with heterozygosity for the methylenetetrahydrofolate reductase C677T mutation.
Presented at the 20th All-Ireland Social Medicine Meeting. Newcastle Co Down, April 2003.
Invited presentations
■ Kirke PN (2003) The Irish genetic study of orofacial clefts: background, objectives and preliminary
results. Presentation to the Dublin Cleft Centre Meeting. Dublin, January 2003.
■ Lynn E (2003) The Irish genetic study of orofacial clefts: recruitment and methodology.
Presentation to the Dublin Cleft Centre Meeting. Dublin, January 2003.
■ Kirke PN (2003) The Irish genetic study of spina bifida and other neural tube defects.
Presentation to public health nurses, Galway Community Care Area. Galway, January 2003.
■ Kirke PN (2003) The Irish genetic study of spina bifida and other neural tube defects.
Presentation to public health nurses, Mayo Community Care Area. Castlebar, February 2003.
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Disability Databases
Considerable progress was made during the year on the two
national service-planning databases for people with disabilities,
the National Intellectual Disability Database (NIDD) and National
Physical and Sensory Disability Database (NPSDD).
As in previous years, the division facilitated the extended use of the databases by approved
researchers in order to develop their research, policy, and planning functions. 
Developments included:
■ Initial development of a web-enabled database for the NPSDD to facilitate the provision of 
real-time information to authorised users
■ An art competition was organised to design the NIDD Annual Report 2003 in association with
the National Federation of Voluntary Bodies
■ An upgrade to the NIDD database resulted in the submission of high-quality data in June 2003
The National Physical and Sensory Disability Database (NPSDD)
Data collection for the NPSDD is actively under way in the seven health boards and the ERHA, with
some health boards making considerable progress towards their overall regional target by year-end.
Throughout the year, measures were taken to further develop this database. It was decided to
develop a centralised, web-enabled database so that up-to-date information can be available to
authorised users in real time. By year-end the software had been developed and tested with the full
involvement of key stakeholders. 
To ensure the NPSDD meets the needs of all stakeholders, the division worked with a NPSDD
Committee Working Group to undertake a multi-faceted consumer satisfaction survey. A report on
this survey is being prepared. 
Another Working Group of the NPSDD Committee is seeking to identify an appropriate measure of
ability and functioning for adults with physical and sensory disabilities. The ability and functioning
measure that was developed was piloted with focus groups in September and will be further
evaluated in early 2004.
The National Intellectual Disability Database (NIDD)
During 2003, the annual reports on the database from 2001 and 2002 were collated and published.
These reports document the extent to which existing specialised health services meet the needs of
this population and identify the assessed need for these services. 
In 2003, a suite of targeted summaries, specific to each health board, was published to complement
the national Annual Report. Each summary contained a complete set of tables from the annual report
relating to an individual health board. 
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To celebrate European Year of People with Disabilities, a competition was organised to design the
cover of the 2003 Annual Report in association with the Federation of Voluntary Bodies providing
Services to People with Intellectual Disability. The initiative received such a positive response that it
will become an annual event. 
The division completed the implementation of approved changes to the NIDD for 2003 in the first
quarter. This included providing training to users in relation to data collection and software use. The
integrity-checking function of the database was significantly upgraded and resulted in the submission
of high-quality data in June 2003. This is the first year that all health boards returned their data on
time, which significantly improves the division’s capacity to publish timely database reports.
One of the key tasks identified by the division for 2003 was the development of a comprehensive
reports module for the NIDD. This module was implemented in October 2003. A new improved
report writing package was also sourced and a national training programme was developed for this
application and delivered to all NIDD software users.
Networking and capacity building
During 2003, the division availed of every opportunity to promote the disability databases at national
and international level. A collaborative study was undertaken with the School of Nursing in Dublin City
University to assess levels of ability and functioning in people with physical or sensory disabilities.
This study, based on data collected during pilot implementation of the NPSDD, has been accepted
for publication in a forthcoming issue of the peer-reviewed journal Disability and Rehabilitation. 
In the second half of the year, the division participated as a member of the Scientific Advisory Board
organising the 2004 World Congress of the International Association for the Scientific Study of
Intellectual Disability (IASSID). The development of a symposium of three papers has been co-
ordinated by the division, in addition to three individual papers that will be presented at the World
Congress. Five of the six papers are based on NIDD information.
Publications
Gallagher P and Mulvany F (in press) Levels of ability and functioning: Using the WHODAS II in an
Irish context. Disability and Rehabilitation.
Mulvany F (2003) National Intellectual Disability Database Committee Annual Report 2001. Dublin:
Health Research Board.
Mulvany F and Barron S (2003) National Intellectual Disability Database Committee Annual Report
2002. Dublin: Health Research Board.
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Drug Misuse Research
The Drug Misuse Research division (DMRD) focused on
delivering quality research and reporting accurate information
from well-managed information systems during 2003. 
This was achieved and the results were used as a basis for national and European research and
service planning. Significant progress was also made in raising the profile of the National
Documentation Centre on Drug Use (NDC). 
Highlights of 2003 included:
■ The National Drug Treatment Reporting System was modified to provide information on access
to treatment and figures on treated problem alcohol use from 2004 onwards.
■ A report on trends in treated drug misuse in Ireland from 1996 to 2000 was published.
■ Three issues of the newsletter Drugnet Ireland were published.
■ The NDC hosted the 15th annual conference of European Library and Information Services on
Alcohol and Drugs. 
■ Research presentations were made at 12 conferences internationally.
National Drug Treatment Reporting System (NDTRS)
This reporting system collates information about treated drug misuse submitted by all health boards.
These data are used at national and European levels to provide information on the characteristics of
clients entering treatment, and on patterns of drug misuse, such as types of drugs used and
consumption behaviours. Information from the NDTRS is used to inform local and national drug
policy and planning. 
■ During 2003, a computer programme was developed to improve the quality of the data entered. 
■ A report on trends in treated drug misuse in Ireland from 1996 to 2000 was published. 
■ During 2003, the reporting system was modified to include performance indicators, which relate
to treatment access and numbers seeking treatment for problem alcohol use; the revised
reporting system will be implemented from 2004 onwards. 
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
The DMRD is the designated Irish Focal Point for the European Information Network on Drugs and
Drug Addiction, co-ordinated by the European Monitoring Centre for Drugs and Drug Addiction
(EMCDDA). Participation in the EMCDDA is a strategic part of the work of the division. Activity during
the year included:
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■ Preparation of a national report on the drug situation in Ireland for the EMCDDA
■ Maintenance and development of Ireland’s contribution to the EMCDDA European Database on
Demand Reduction Activities (EDDRA) 
■ Ongoing development of the existing five epidemiological key indicators of drug misuse, with a
view to improving national data sources and increasing the comparability of Irish and EU data
■ Assistance in the development of a new structured questionnaire on alternatives to prison for
drug-using offenders
■ Continued work with the EMCDDA and other Focal Points on conceptualising new indicators of
drug misuse and identifying new areas for research
National Documentation Centre on Drug Use (NDC)
The NDC provides access to all relevant and up-to-date information and research in the field of drug
use in Ireland. During the year, policy-makers, health professionals, researchers, the media and the
general public made use of this valuable resource. Landmarks in 2003 included:
■ Four hundred Irish research documents were transcribed from the original hard copies and
entered into the NDC electronic online database.
■ The library collection now comprises 2,000 volumes (more than 1,500 separate titles).
■ The NDC dealt with more than 700 individual queries during 2003 by email, phone and letter.
■ The NDC website had 283 registered users at the end of 2003.
■ The Centre hosted a major international conference of information specialists attended by
delegates from 18 European and North American countries.
■ NDC staff were elected to officer positions in the European Library and Information Services on
Alcohol and Drugs and the Irish Health Sciences Library Group.
Networking and building capacity
The need to work with Irish agencies to help address priority information needs in the area of drug
misuse in Ireland drives a strong networking agenda. DMRD staff participated in a wide variety of
national and regional committees and working groups, including:
■ The National Advisory Committee on Drugs and its sub-committees 
■ The Health Implementation Committee of the National Drugs Strategy, Department of Health 
and Children
■ An Garda Síochána Steering Group on opiate use and related criminal activity in Ireland
■ The Irish Health Science Libraries Group
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Increased knowledge and expertise contributes to national capacity. The division had a role in
informing policy through two written submissions:
■ Statistics on drug-related crime to an expert group established by the Minister for Justice,
Equality and Law Reform
■ Key contributions to the future work programme of the National Advisory Committee on Drugs 
In Europe, the division participated and provided expert advice at: 
■ More than 10 EMCDDA expert meetings
■ The European network on HIV and Hepatitis Prevention in Prison
■ The Pompidou Group meeting on treatment demand
■ The UN, EMCDDA and Pompidou Group expert meeting on treatment demand indicators and
international collaboration in drug-abuse epidemiology
Publications
O’Brien M, Kelleher T, Cahill P, Kelly F and Long J (2003) Trends in treated drug misuse in the
Republic of Ireland, 1996 to 2000. Occasional Paper No. 9. Dublin: Health Research Board.
Drug Misuse Research Division (2003) Ireland: Drug Situation 2002. Dublin: Health Research Board.
Drug Misuse Research Division (2003) Drugnet Ireland. Issue 7, February 2003. Dublin: Health
Research Board.
Drug Misuse Research Division (2003) Drugnet Ireland. Issue 8, June 2003. Dublin: Health Research
Board.
Drug Misuse Research Division (2003) Drugnet Ireland. Issue 9, November 2003. Dublin: Health
Research Board.
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Presentations
■ Fear and Denial: How prisoners cope with risk of or diagnosis with Hepatitis C. Poster
presentation to 13th All-Ireland Social Science and Medicine Meeting. Newcastle, Co Down, 
April 2003.
■ Hepatitis C and tattooing in prison. Poster presentation to Hepatitis C Past, Present and Future
International Conference. Dublin, May 2003.
■ Fear and Denial: How prisoners cope with risk of or diagnosis with Hepatitis C. Poster
presentation to Hepatitis C Past, Present and Future International Conference. Dublin, May 2003.
■ Prisoners’ views of injecting drug use and harm reduction in Irish prisons. Oral presentation to
European Network of Drug Services in Prison 7th International Conference. Rome, May 2003.
■ Fear and Denial: how prisoners cope with risk of or diagnosis with hepatitis C. Poster
presentation to European Network of Drug Services in Prison 7th International Conference.
Rome, May 2003.
■ Prevalence: A key indicator of drug use for national and European needs. Oral presentation to a
prevalence conference hosted by the National Advisory Committee on Drugs. Dublin, May 2003.
■ Drugs, Crime and Community – Monitoring quality of life in the north inner city. Oral presentation
to North Inner City Drugs Task Force conference on drug-related crime in the community.
Dublin, June 2003.
■ The ‘Bradshaw Report’: 20 years on. Oral presentation to Elisad Conference. Dublin, 
September 2003.
■ Research methods on drug misuse. Oral presentation to Elisad Conference. Dublin, 
September 2003.
■ Costs and benefits of harm reduction in Irish prisons. Oral presentation to conference on dealing
with drug use in prison: reviewing the European experience and sharing good practice. Warsaw,
September 2003.
■ The role of an EDDRA manager at national level: the Irish experience. Oral presentation to
EMCDDA EDDRA co-ordinators’ meeting. Lisbon, December 2003.
■ An overview of the prevalence of and risk factors for blood-borne viruses in Irish prisons. 
Oral presentation at Conference to Examine HIV/AIDS and Hepatitis C in Prisons. Dublin,
December 2003.
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Mental Health Research 
During 2003, a variety of new initiatives were introduced in
addition to the ongoing research and maintenance of the
National Psychiatric In-patient Reporting System (NPIRS).
The division’s research expertise continued to be recognised
through representation on a number of research advisory
committees and invitations to submit to policy documents.
New initiatives
A number of high-level meetings were held to establish the information and research-related needs of
clinicians and managers in the mental health area, with a view to expanding the research programme.
A consistent theme emerged, which focused on the need to capture community psychiatric activity
data in a systematic way. In response to this, a computer programme for community care (COMCAR)
was developed to capture activities in community psychiatric services. 
A new study commenced on involuntary admissions to psychiatric hospitals and units throughout the
country. This is being conducted on behalf of the Mental Health Commission. 
The National Psychiatric In-Patient Reporting System (NPIRS)
NPIRS continued to provide national data for academics and service providers to support research
and policy. Key developments in relation to this project included:
■ Further modules of the NPIRS database were included in the Public Health Information System,
increasing the constituency with access to the NPIRS data.
■ An increasing number of psychiatric facilities returning data to the NPIRS began using the HRB
electronic Patient Administration System. This resulted in a quicker, more efficient return of data.
■ A training programme was delivered to more than 100 health board staff nationwide. This also
led to considerable improvements in the quality and timeliness of incoming information for the
NPIRS database.
■ Meetings were held with stakeholders to promote use of NPIRS as a research, policy and
planning tool.
■ Implementation of the results of an audit lead to the closure of the county psychiatric case registers.
■ The NPIRS Annual Report was published in 2003, along with eight Bulletins providing NPIRS
results for each health board individually.
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Networking and building capacity
The MHRD continued working with the National Mental Health Performance Indicator Group of the
Department of Health and Children. A list was compiled of health boards that want to avail of HRB
services in relation to reporting on performance indicators in the mental health area.
A number of joint initiatives were developed to achieve more standardised database procedures and
information exchange with the other divisions operating information systems in the HRB. This
increased inter-divisional co-operation.
Key contributions were made in relation to building national capacity through proposals and
contribution to strategy. Submissions were made in relation to:
■ Action Plan on Homelessness in Dublin 2004–2006
■ Pathways to Involuntary Admission to Psychiatric Hospitals and Units (Mental Health
Commission) 
■ Community Psychiatric Residence Study (Mental Health Commission)
Division staff participated in the following committees:
■ National Mental Health Performance Indicator Working Group
■ Children and Adolescent Psychiatric Service Working Group
■ Research Advisory Group Membership – National Disability Authority, National Counselling
Service
■ ERHA Information Technology Strategy Group
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Publications 
Hickey T, Moran R and Walsh D (2003) Psychiatric Day Care – An underused option? Dublin: Health
Research Board.
Daly A and Walsh D (2003) Activities of Irish Psychiatric Services 2002. Dublin: Health Research Board.
Daly A with NPIRS Team (2003) NPIRS Bulletins 2002. One for each health board. Dublin: Health
Research Board.
Daly A and Walsh D (2003) Activities of Irish Psychiatric Services 2001. Dublin: Health Research Board.
Daly A with NPIRS Team (2003) NPIRS Bulletins 2001. One for each health board. Dublin: Health
Research Board.
Keogh F, Finnerty A, O’Grady Walshe A, Daly I, Murphy D, Lane A and Walsh D (2003) Meeting the
needs of people with schizophrenia living in the community: a report from a European collaboration.
Irish Journal of Psychological Medicine, 20(2):  45–51.
Corcoran E and Walsh D (2003) Obstructive asphyxia: a cause of excess mortality in psychiatric
patients. Irish Journal of Psychological Medicine, 20(3): 88–90.
Kelly B, Walsh D, Feeney L, O’Callaghan E, Browne R, Byrne M, Mulryan N, Scully A, Morris M,
Kinsella A, Takei N, McNeil T and Larkin C (in press) Obstetric adversity and age at first presentation
in schizophrenia: evidence of a dose-response relationship. American Journal of Psychiatry. 
Kelly B, Walsh D, Cotter D, Denihan C, Larkin D, Murphy P, Kinsella A, Waddington J, Larkin C,
O’Callaghan E and Lane A (in press) Neurological soft signs and dermatoglyphic anomalies in twins
with schizophrenia. European Psychiatry.
Thiselton DL, Webb BT, Neale B, Ribble RC, O’Neill FA, Walsh D, Riley BP and Kendler K (in press)
No evidence for linkage or association of Neuregulin-1 (NRG1) with disease in the Irish study of high
density schizophrenia families.
Fanous A, Van den Ord E, Riley B, Aggen SH, Neale MC, O’Neil A, Walsh D and Kendler K (in press)
A high risk Haplotype in the Dystrobrevin-1 Binding Protein Gene (DTNBP1) is associated with
negative symptoms of schizophrenia. American Journal of Psychiatry.
Research presentations
Walsh D. Psychiatric Resources and Services Ireland 1963–2003. Oral presentation to Mental Health
Ireland Conference. Dundalk, May 2003.
Moran R. The role of the MHRD in provision of performance indicators in the mental health area.
Presentations to National Mental Health Performance Indicator Group, Quarterly in 2003.
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Corporate Services 
A wide variety of initiatives were developed in 2003 to
improve the operational capacity and create greater
transparency throughout the organisation. 
Key highlights included:
■ Introduction of an internal audit system
■ Formalisation of the HRB research ethics procedures
■ Preparation for the implementation in the HRB of the Freedom of Information Act
■ Major refurbishment of the HRB office accommodation and relocation of office space 
■ Upgrading of HRB network, network security, and teleworking/remote-working access methods
■ Introduction of a new format for monthly corporate management accounts
An internal auditing service was developed, which included drafting a charter for internal audit and
preparation of a draft risk register. A financial expert was appointed to the Audit Committee and roles
and responsibilities of the committee were delivered through a comprehensive training programme. 
In line with best international practice, a policy and procedures manual in relation to research ethics
was developed for researchers to use when submitting proposals for review by the HRB Research
Ethics Committee. This manual was approved by the Research Ethics Committee and adopted by
the Board.
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An implementation team was established to meet the requirements of the Freedom of Information
(FOI) legislation. Key deliverables of the group included:
■ Completion of the ‘Section 15’ manual and progress on the ‘Section 16’ manual, two guides to
help the public access information from the HRB 
■ Co-ordination of FOI training for all staff 
■ Appointment of FOI decision makers and reviewers 
■ Development and specification of a records-management policy and database
The refurbishment of the interior of the HRB office at 73 Lower Baggot Street, a listed Georgian
building, was completed on time, to a high standard and within budget. Transfer of staff and facilities
was successfully completed in line with health and safety standards, with the minimum of ‘down
time’ or impact on services.
Upgrading of IT hardware and software continued during 2003 to increase capacity and maintain
security. Ongoing training of staff ensured that the HRB was up to date with all the latest IT
developments. 
The Finance team continued to provide a dedicated service to the organisation and built on
standards, which resulted in a clean audit report from the Comptroller and Auditor General in 2003.
Key activities included:
■ A new format for monthly corporate management accounts was devised and approved by the
Audit Committee for reporting to the Board.
■ Financial audits were completed on the research funding management procedures at TCD, UCC,
DCU, and the Research Unit on Health Status and Health Gain at UCD. 
■ Reviews were conducted on financial reports relating to research expenditure funded by
Research and Development for Health.
■ A computerised expenses claims system, compatible with the requirements of the HRB, was
identified and implemented.
■ The payments functionality of the Grants Database was developed and tested for use by the
Finance team.
■ Expert financial advice and assistance was provided to divisions of the HRB undertaking special
or non-routine activities.
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Human Resources 
Significant progress was made in 2003 towards establishing the HRB as an employer of choice. In a
staff opinion survey, the HRB scored in the top third of comparable organisations in Ireland. 
The foundations were laid for the introduction of an organisation-wide performance management and
development system. This was piloted successfully at senior management level and all staff agreed
individual development plans. A scheme for the review of the performance of the chief executive was
submitted to the Department of Health and Children for approval.
A human resource strategy for the organisation was drafted. Policies and procedures on discipline,
problem resolution, career development, training, personal development, further education and
recruitment and selection processes were initiated. Significant progress was also made on setting up
an employee assistance programme. 
Training is a core tool in the development of staff and the organisation. To support this, all managers
and staff completed workshops on setting objectives and individual development planning. A HRB
training plan for the period July 2003 to June 2004 was adopted and all staff used a variety of
options, including training, further education and the learning centre, for development purposes.
Communications 
During 2003, the communications office continued to build and develop the corporate branding of
the HRB. Ongoing support was provided to all the divisions to highlight progress and achievements
through events, launches, reports and media relations. 
The first organisational media plan was developed. The volume and quality of media coverage
achieved in the period January to December 2003 reflected the success of the plan. More than 330
articles were profiled in the press, amounting to 100,000 square centimetres of coverage, which
represents €600,000 in advertising equivalent. 
The HRB was the main sponsor in 2003 of the Journal of Medical Science research awards, an event
that highlights the value of health research and the contribution of health researchers in Ireland. A
number of the awards were made to researchers funded by the HRB. 
Participation in the 2003 ESAT BT Young Scientist and Technology competition and exhibition was
very successful. This was the first time that the HRB had participated in this event and the exhibit
attracted much interest in health research from the young participants, their parents and teachers.
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Financial Statements for the year ended 
31 December 2003
Statement of Board Members’ Responsibilities
The Board is required by the Health Research Board (Establishment) Order, 1986, as amended, to
prepare Financial Statements for each financial year which give a true and fair view of the state of
affairs of the Health Research Board and of its income and expenditure for that period. In preparing
those Financial Statements the Board is required to:
■ select suitable accounting policies and apply them consistently
■ make judgements and estimates that are reasonable and prudent
■ state whether applicable accounting standards have been followed, subject to any material
departures disclosed and explained in the financial statements
■ prepare the Financial Statements on the going concern basis unless it is inappropriate to
presume that the Health Research Board will continue in operation
The Board is responsible for keeping proper books of accounts, which disclose with reasonable
accuracy at any time the financial position of the Health Research Board and enable it to ensure that
the Financial Statements comply with the Order. It is also responsible for safeguarding the assets of
the Health Research Board and hence for taking reasonable steps for the prevention and detection of
fraud and other irregularities.
On behalf of the Board
Professor Desmond Fitzgerald Mr Charlie Hardy
Chairman Board Member
25 November 2004
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Statement of Internal Financial Control
On behalf of the Board of the Health Research Board I acknowledge we are ultimately responsible for
the system of internal financial control, for reviewing its effectiveness and ensuring it is maintained
and operated.
However, such a system is designed to manage rather than eliminate the risk of failure to achieve the
organisation’s objectives, and can provide only reasonable and not absolute assurance against
material misstatement or loss.
The Board has taken steps to ensure an appropriate control environment is in place. The key
elements of the system are:
■ There is a clear focus on organisational objectives as determined by the Board in its Corporate
Strategy, after consideration of the statutory responsibilities.
■ A clearly defined organisation structure, with appropriate segregation of duties and limits of
authority designed to foster a beneficial control environment, is outlined.
■ Annual budgets are approved by the Board. 
■ Monthly management accounts are presented to the Management team and the most recently
available management accounts are presented to the Board at their scheduled meetings.
■ Clearly defined procedures for financial expenditure including research funding, procurement and
capital expenditure are agreed at Board level, ensuring there are no conflicts of interest present.
■ Management prepares an annual business plan for adoption by the Board. Management report to
the Board on an ongoing basis on the activities of each division and on progress in achieving
corporate and divisional objectives against the business plan. The reports cover operational and
financial performance, ensure that budgetary variances are examined and addressed properly and
that activities of the divisions are monitored to ensure they are in line with the Health Research
Board’s organisational objectives.
■ A Board-level committee, the Audit Committee, meets regularly and deals with significant control
issues. The Audit Committee approves the year-end financial statements before submission to
the Board and is reported to directly by the Internal Auditors.
■ Management is responsible for the identification and evaluation of significant risks applicable to their
divisions of the organisation, together with the design and operation of suitable internal controls. 
■ The Health Research Board has outsourced its internal audit function. In accordance with the
Code of Best Practice for the Governance of State Bodies, the Internal Auditors report directly to
the Audit Committee.
A full formal review of Internal Financial Controls was not carried out during 2003 but it will be
completed during 2004.
On behalf of the Board
Professor Desmond Fitzgerald
Chairman
25 November 2004
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Report of the Comptroller and Auditor General for presentation to the
Houses of the Oireachtas 
I have audited the financial statements on pages 34 to 46 under the Health Research Board
(Establishment) Order, 1986 (as amended).
Respective Responsibilities of the Members of the Board and the
Comptroller and Auditor General
The accounting responsibilities of the Members of the Board are set out on page 31. It is my
responsibility, based on my audit, to form an independent opinion on the financial statements
presented to me and to report on them.
I review whether the statement on page 32 reflects the Board’s compliance with applicable guidance
on corporate governance and report any material instance where it does not do so, or if the
statement is misleading or inconsistent with other information of which I am aware from my audit of
the financial statements.
Basis of Audit Opinion
In the exercise of my function as Comptroller and Auditor General, I conducted my audit of the
financial statements in accordance with auditing standards issued by the Auditing Practices Board
and by reference to the special considerations which attach to State bodies in relation to their
management and operation. 
An audit includes examination, on a test basis, of evidence relevant to the amounts and disclosures
in the financial statements. It also includes an assessment of the significant estimates and judgments
made in the preparation of the financial statements, and of whether the accounting policies are
appropriate to the Board’s circumstances, consistently applied and adequately disclosed.
I planned and performed my audit so as to obtain all the information and explanations that I
considered necessary to provide me with sufficient evidence to give reasonable assurance that the
financial statements are free from material misstatement whether caused by fraud or other irregularity
or error. In forming my opinion I also evaluated the overall adequacy of the presentation of information
in the financial statements. 
Opinion
In my opinion, proper books of account have been kept by the Board and the financial statements,
which are in agreement with them and have been properly prepared in accordance with accounting
policies laid down by the Minister for Health and Children, give a true and fair view of the state of
affairs of the Health Research Board at 31 December 2003 and of its income and expenditure and
cash flow for the year then ended.
John Purcell
Comptroller and Auditor General
30 November 2004
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34 Statement of Accounting Policies
Basis of Accounting
The Financial Statements are prepared under the historical cost convention and in accordance with
generally accepted accounting principles.
Income Recognition
The Department of Health and Children’s Revenue Grant is credited to the income and expenditure
account in full in the year it is allocated. Capital Grants are accounted for on an accruals basis. All
other research funding is recognised as income when it is used to offset matching expenditure. Such
funding includes a contribution towards the administration costs of the Board.
Expenditure Recognition
Funding for research awards is recognised as expenditure in the period in which it is due for payment
to the award holder. All other expenditure is recognised on an accruals basis.
Tangible Fixed Assets
Tangible fixed assets are stated at cost less accumulated depreciation. The charge for depreciation is
calculated to write down the cost of the tangible fixed assets to their estimated residual values, by
annual instalments over their expected useful lives on the following basis:
Premises 4%
Office Furniture and Equipment 15%
Computer Equipment 25%
Tangible fixed assets costing less than €650 are not capitalised.
Debtors
Known bad debts are written off and specific provision is made for any amounts the collection of
which is considered doubtful.
Pensions
Permanent staff are members of the Local Government Superannuation Scheme. Pensions arising
under this scheme are paid out of current funds as they arise, and pension contributions deducted
from staff are netted against pension payments as shown in note 5. No provision has been made in
the accounts in respect of accrued superannuation benefits payable in future years. 
The Board also operates a defined benefit pension scheme. This scheme provides pension benefits
to staff that were employed by the Board prior to the extension of the Local Government
Superannuation Scheme to its employees. 
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35The fund is vested in independent trustees nominated by the Board, for the benefit of existing
pensioners, former employees with preserved benefits and their dependants. An independent
qualified actuary periodically assesses the adequacy of the fund to meet pension liabilities. The most
recent actuarial valuation showed the scheme to be in surplus and for this reason the Board did not
make contributions to the fund.
Operating Leases
Rental payments are charged to the revenue income and expenditure account in the year to which
they relate.
Health Research Board
Revenue Income and Expenditure Account for the year ended 31 December 2003
Notes 2003 2002
€ €
Income
Department of Health and Children Revenue Grant 14,342,000 13,008,000
Other Research Funding 1 2,321,517 2,625,765
Projects Undertaken for the Department of
Health and Children 2 5,977,679 5,240,893
Interest Receivable 32,919 75,745
22,674,115 20,950,403
Expenditure
Research Funding and Policy 3 14,486,081 13,584,894
Child Health Epidemiology 1,370,179 1,095,539
Drug Misuse Research 742,017 639,973
Mental Health Research 703,616 1,148,690
Disability Databases 368,531 222,413
R&D for Health 3,106,333 2,622,762
Administration Costs and General Overheads 4 1,820,220 1,492,783
Pensions Paid to Retired Members of Staff 5 33,546 47,811
Other Activities 52,484 78,789
22,683,007 20,933,654
(Deficit)/Surplus for the Year (8,892) 16,749
All income and expenditure for the year ended 31 December 2003 relates to continuing activities.
The Board has no recognised gains or loses other than those dealt with in the revenue and capital
Statements of income and expenditure.
The Statement of Accounting Policies and notes 1 to 16 form part of these Financial Statements.
Professor Desmond Fitzgerald Mr Charlie Hardy
Chairman Board Member
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Health Research Board
Capital Income and Expenditure Account for the year ended 31 December 2003     
2003 2002
€ €
Income
Department of Health and Children Capital Grant 4,564,910 1,882,073
Amortisation of Capital Fund Account 151,630 132,734
4,716,540 2,014,807
Expenditure
Equipment Grants Paid to Third Parties 3,550,773 1,251,740
ICT Development 107,761 - 
Contribution to Fixed Assets 187,697 279,834
Maintenance of Premises 718,679 350,499
Depreciation 151,630 132,734
4,716,540 2,014,807
(Deficit)/Surplus for the Year - - 
The Statement of Accounting Policies and notes 1 to 16 form part of these Financial Statements.
Professor Desmond Fitzgerald Mr Charlie Hardy
Chairman Board Member
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Health Research Board
Balance Sheet as at 31 December 2003
Notes 2003 2002
€ €
Fixed Assets
Tangible Assets 6 581,312 545,803
Current Assets
Debtors 7 2,384,345 1,917,133
Investments 8 641 641
Cash at Bank and on Hand 2,173,434 2,610,245
4,558,420 4,528,019
Current Liabilities
Amounts falling due within one year:
Bank and Other advances 9 - 527,196
Creditors and Deferred Income 10 4,496,964 3,930,475
4,496,964 4,457,671
Net Current Assets 61,456 70,348
Net Assets 642,768 616,151
Reserves
Accumulated Surplus on
Income & Expenditure Account 11 61,456 70,348
Capital Fund 12 581,312 545,803
642,768 616,151
The Statement of Accounting Policies and notes 1 to 16 form part of these Financial Statements. 
Professor Desmond Fitzgerald Mr Charlie Hardy
Chairman Board Member
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Health Research Board
Cash Flow Statement for the year ended 31 December 2003
Notes 2003 2002
€ €
Reconciliation of Operating (Deficit)/Surplus to
Net Cash Inflow from Operating Activities
(Deficit)/Surplus for the Year (8,892) 16,749
Less Interest Receivable (32,919) (75,745)
(Increase) in Debtors (467,212) (981,290)
Increase in Creditors and Deferred Income 566,489 14,744
Net Cash Inflow/(Outflow) from Operating Activities 57,466 (1,025,542)
Net Cash Inflow from Returns on 
Investments and Servicing of Finance 32,919 75,745
Amount Allocated to Fund Fixed Asset Additions (187,697) (279,834)
Net Cash (Outflow) from Operating Activities (97,312) (1,229,631)
Investing Activities 
Expenditure on Fixed Assets 187,697 279,834
Increase/(Decrease) in Cash and Cash Equivalents 13 90,385 (949,797)
The Statement of Accounting Policies and notes 1 to 16 form part of these Financial Statements.  
Professor Desmond Fitzgerald Mr Charlie Hardy
Chairman Board Member
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Health Research Board
Notes to the Financial Statements for the year ended 31 December 2003      
1. Other Research Funding 2003 2002
€ € € €
Research Award Schemes
Women’s Health Council 116,606 122,472
Arthritis Foundation - 38,092 
Department of the Environment 32,993 52,832
The Hadwen Trust 25,395 25,395 
The British Council 9,009 - 
The Irish Hospice Foundation 24,785 - 
208,788 238,791
Child Health Research
National Institute of Child Health
and Human Development (USA) 1,295,078 1,060,982
1,295,078 1,060,982
Drug Misuse Research 
Community Rural & Gaeltacht Affairs 302,121 261,707
European Monitoring Centre for
Drugs and Drug Addiction 110,000 110,000 
412,121 371,707
Mental Health Research
East Coast Area Health Board 246,598 213,457
Virginia Commonwealth University 158,932 740,828
405,530 954,285
2,321,517 2,625,765
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Health Research Board
Notes to the Financial Statements for the year ended 31 December 2003  
2. Projects undertaken for the 2003 2002
Department of Health and Children € € € €
Research Award Schemes
Hepatitis C Research 932,444 450,634
Autism and Intestinal Dysfunction 63,500 63,500
Nursing and Midwifery Research 632,278 522,556
Health Status Research 76,000 76,000
North-South Research Schemes 663,449 981,802
Cancer Research 2,680,019 2,322,252
5,047,690 4,416,744
Drug Misuse Research 342,863 268,266
Mental Health Research 203,000 254,682
Disability Databases 368,531 222,413   
Other Activities
Wellcome Trust VAT Refund Scheme 15,595 78,788
5,977,679 5,240,893
3. Research Funding and Policy 2003 2002
€ €
General Research Project Grants 6,725,018 6,277,535   
Programme Grants 2,348,082 1,849,134   
North/South Co-operative Research Grants 663,449 981,802   
Discipline Integration Grants 227,390 234,418
Co-operative Health Services Research Grants 51,820 75,030   
Research Visits Scheme (1,498) 9,750   
Summer Student Grants 39,106 61,108   
Post Doctoral Research Fellowships 990,840 953,950   
Clinical Research Training Fellowships 547,176 944,815   
Health Services Research Fellowships 680,699 657,891   
Nursing and Midwifery Research Fellowships 573,474 395,583   
Hepatitis C Research 932,444 450,634   
Hadwen Trust 51,092 51,093   
General Divisional Costs 656,989 642,151
14,486,081 13,584,894
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Health Research Board
Notes to the Financial Statements for the year ended 31 December 2003    
4. Administration Costs and 2003 2002
General Overheads € €
Salaries and Pensions 671,917 566,148   
Employee Costs 18,855 16,092   
Sponsorship 1,600 37,800   
Travel, Subsistence and Training 17,645 37,737  
Insurance 81,248 67,677   
Printing and Stationery 31,954 38,885   
Postage 15,823 17,781   
Telephone 36,803 35,983   
Light and Heat 17,672 18,279   
Repairs/Rent/Rates 103,750 56,601   
Cleaning 35,172 35,512   
Subscriptions to International Organisations 10,426 3,342   
Books and Journals - 6,794   
Bank Interest and Charges 1,561 2,335   
Annual Reports and Newsletters 3,749 24,682   
Computer Costs 125,313 159,601   
Website 51,448 34,446   
Consultancy 85,584 45,478   
Hospitality 6,178 7,522   
Communications 95,186 34,129   
Audit Fees 6,500 6,560   
Advertising 575 25,219   
Human Resources 171,518 64,001   
Office Service Charges 35,371 11,218   
Office Rental 194,372 138,960
1,820,220 1,492,783   
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Health Research Board
Notes to the Financial Statements for the year ended 31 December 2003
5. Pensions Paid to Retired Members of Staff 2003 2002
€ €
Pension Payments 141,657 134,808  
Less: Contributions from Current Staff (108,111) (86,997)
33,546 47,811
6. Fixed Assets – Tangible Assets
Office
Furniture &
Premises Equipment Computers Total
€ € € €
Cost
At beginning of year 384,783 403,721 345,134 1,133,638
Additions - 59,711 127,986 187,697
Disposals - (31,499) (108,788) (140,287)  
At end of year 384,783 431,933 364,332 1,181,048
Depreciation
At beginning of year 171,951 182,939 232,945 587,835
Charge for year 15,391 59,933 76,306 151,630
Disposals - (30,941) (108,788) (139,729)  
At end of year 187,342 211,931 200,463 599,736
Net Book Value
At 31 December 2003 197,441 220,002 163,869 581,312
At 31 December 2002 212,832 220,782 112,189 545,803
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Health Research Board
Notes to the Financial Statements for the year ended 31 December 2003                        
7. Debtors 2003 2002
€ €
Department of Health and Children 1,612,376 152,797
Other Debtors 618,370 1,418,500
Prepayments and Sundry Receivables 153,599 345,836
2,384,345 1,917,133      
8. Investments 2003 2002
€ €
At Cost At Cost
Prize Bonds 641 641
641 641
9. Bank and Other Advances 2003 2002
Amounts falling due within one year: € €
Bank Overdraft - 527,196
10. Creditors and Deferred Income 2003 2002
Amounts falling due within one year: € €
Creditors and Accruals 2,158,389 1,598,774
Deferred Income 2,338,575 2,331,701
4,496,964 3,930,475
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Health Research Board
Notes to the Financial Statements for the year ended 31 December 2003
11. Accumulated Surplus on 2003 2002
Income and Expenditure Account € €
At the beginning of the year 70,348 53,599
(Deficit)/Surplus for the year (8,892) 16,749
Retained Surplus 61,456 70,348
12. Capital Fund 2003 2002
€ €
At the beginning of the year 545,803 398,703
Transfer from Capital Income and 
Expenditure Account to fund Fixed Assets 187,697 279,834
Depreciation charge for the year (151,630) (132,734)
Disposal of Fixed Assets (558) - 
At the end of the year 581,312 545,803
13. Analysis of Cash and Cash Equivalents Change in year Change in year
2003 2002
€ €
Investments - (445,319)
Cash at Bank and on Hand (436,811) (13,560)
Bank Overdraft 527,196 (490,918)
90,385 (949,797)
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Health Research Board
Notes to the Financial Statements for the year ended 31 December 2003
14. Operating Leases
The Health Research Board has commitments in respect of two leases on office accommodation.
a) 19 Clanwilliam Terrace, Dublin 2.
This is held by way of a 25-year lease, which commenced in 2001. The annual cost of the lease
is approximately €57,100.
b) Floor 2, Holbrook House, Holles Street, Dublin 2.
This is held by way of a 25-year lease, which commenced in 2002. The annual cost of the lease
is approximately €180,000.
15. Board Members’ Interests
Grants are, from time to time, made to bodies with which members are connected whether through
employment or otherwise.  The Board has procedures for dealing with conflicts of interest, in
accordance with the terms of section 13 of the Board’s statutory instrument.
16. Board Approval
The Financial Statements were approved by the Board on 25 November 2004
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Grant Holder Project Title
Dr Richard Costello Laser capture microdissection
Department of Medicine 
Royal College of Surgeons in Ireland 
Dublin 2
Professor Tom Cotter Laser capture microscopy: its uses in 
Department of Biochemistry neurodegenerative and related diseases
University College Cork
Cork
Dr Derek Doherty MicroBeta Trilux scintillation counter
Department of Biology 
National University of Ireland
Maynooth, Co Kildare
Professor Desmond Fitzgerald Nano-HPLC system for high-resolution proteomics
Department of Clinical Pharmacology
Royal College of Surgeons in Ireland 
Dublin 2
Ms Mary Fitzsimons Infrastructure to support the development of an
Department of Neurology epilepsy electronic patient record (EPR)
Epilepsy Programme
Beaumont Hospital 
Dublin 9
Dr William Gallagher Clinical Proteomics Instrumentation
Department of Pharmacology 
University College Dublin 
Dublin 4
Dr Adrienne Gorman Real-time fluorescent imaging of biological samples
Department of Biochemistry
National University of Ireland
Galway
Dr Ziarih Hawi An ABI 3100 genetic analyzer for Linkage 
Department of Genetics Disequilibrium (LD) mapping of genes and 
Trinity College Dublin regions of association with attention deficit 
Dublin 2 hyperactivity disorder (ADHD) and autism in the 
Irish population
Professor Donal Hollywood A tele-archiving and data warehouse linked to the 
Institute of Molecular Medicine the Telesynergy multimedia medical imaging 
Faculty of Health Sciences workstation network
St James’s Hospital
Dublin 8
A
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47Appendix: Grants Awarded in 2003
Grant Holder Project Title
Professor Dermot Kelleher Advanced multi-user cell biology infrastructure 
Department of Clinical Medicine
Trinity College Dublin 
Dublin 2
Professor Paul McLoughlin Stereological mophometry: quantitative 
Department of Human Anatomy and Physiology assessment of disease-induced angiogenesis and 
University College Dublin tissue remodelling in vivo.
Dublin 2
Dr Hilary McMahon Prion equipment application 2003
Department of Industrial Microbiology 
University College Dublin 
Dublin 4
Dr Evelyn Murphy Nucleofection technology for gene delivery and 
Department of Biochemistry and Physiology gene silencing in primary cells and transfection-
Conway Institute of Biomedical and resistant cell lines
Biomolecular Research
University College Dublin
Dublin 4
Professor Timothy O’Brien Fluorescence-activated cell sorter instrument to
Department of Medicine  support gene- and cell-based therapeutic 
University College Hospital approaches to vascular disease
Galway 
Professor Eadbhard O’Callaghan Carer education for schizophrenia via tele - networks
Department of Adult Psychiatry
Cluain Mhuire Service
St John of God Hospital 
Dublin
Professor Kay Ohlendieck Establishment of a mass spectroscopy unit at NUI 
Department of Biology Maynooth for the support of biomedical research
National University of Ireland 
Maynooth
Professor John O’Leary Applied Biosystems 7900 microfluidics system
Department of Histopathology 
Trinity College Dublin 
Dublin 2
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Grant Holder Project Title
Professor Luke O’Neill Signal transduction pathways activated by the 
Department of Biochemistry novel adapter protein Mal (MyD88-adapter like),
Trinity College Dublin a critical participant in Toll-like receptor-4 action
Dublin 2
Dr Emer Shelley National Cardiovascular Information Systems, 
Department of Heart Health Multidisciplinary Interagency Infrastructure 
Department of Health and Children Project (NCIS MIIP)
Dublin 2
Dr Peter Wright Developing a Health Intelligence Unit: Using 
Department of Public Health geographical mapping systems to improve 
North Western Health Board health status and to monitor health gain
Ballyshannon, Co Donegal
Fellowships – Clinical Research Training
Dr Glen Doherty Downstream effectors of cyclooxygenase-2 in 
Department of Clinical Pharmacology colorectal cancer
Royal College of Surgeons in Ireland 
Dublin 2
Dr Amjad Hayat Chronic lymphocytic leukaemia: New insights in its
Department of Molecular Medicine biological heterogeneity and identification of 
St James’s Hospital prognostic markers
Dublin 8
Dr Eamonn Molloy Calcium-containing crystals – a potential target 
Department of Clinical Pharmacology for selective disease modification in osteoarthritis
Royal College of Surgeons in Ireland 
Dublin 2
Fellowships – Health Services Research
Mr Philip Larkin Transition towards specialist palliative care services:
Centre for Nursing Studies An exploration of its meaning for palliative care
National University of Ireland patients in Europe
Galway 
Dr Fergal Moloney Pharmacogenetic prevention of skin cancer in 
Clinical Science Institute renal transplant patients 
Beaumont Hospital
Dublin 9
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Grant Holder Project Title
Mr Conor Teljeur The impact on population health of exposure to
Department of Community Health and multiple forms of deprivation
General Practice 
AMNCH 
Tallaght, Dublin 24
Fellowships – Nursing and Midwifery
Ms Claire Hayes Fathers’ experiences of managing the care of 
School of Nursing and Midwifery their children with cystic fibrosis:  A
University College Cork phenomenological study
Cork
Ms Agnes Higgins An exploration of sexuality in a psychiatric 
School of Nursing and Midwifery Studies context from the perspective of the psychiatric 
St James’s Hospital nurse and people with mental health problems
Dublin 8
Ms Joan Lawlor A longitudinal study of women’s experiences of 
School of Nursing and Midwifery Studies carrying a baby with fetal abnormality up to and
Trinity College Dublin beyond the birth: A Grounded Theory approach
Dublin 2
Ms Catherine Redmond The development and validation of physiological 
Department of Physiology measures of pre-sleep arousal suitable for use in
University College Dublin nursing research
Dublin 2
Fellowships – Post-Doctoral
Dr Sandra Austin Regulation of gene expression by Cyclooxygenase-
Department of Clinical Pharmacology 2 in cardiovascular tissue
Royal College of Surgeons in Ireland 
Dublin 2
Dr Derek Morris Developing haplotype maps: a novel approach
Department of Psychiatry approach to identifying susceptibility genes for 
St James’s Hospital complex disorders
Dublin 8
Dr Kenneth Nally Elucidation of the molecular mechanisms 
Department of Medicine underlying Interferon-y mediated sensitisation of 
Cork University Hospital colon cancer cells to death receptor-triggered 
Cork (TNF- R1, Fas/CD95 and TRIAL) apoptosis
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Grant Holder Project Title
Fellowships – Primary Care
Dr Waisun Chan Evaluation of a lengthened and multi-disciplinary 
Family Medicine and General Practice consultation model in a socially deprived 
Royal College of Surgeons in Ireland community
Dublin 2
Dr Una Fallon Patterns of primary health care utilisation and 
Department of Social Medicine referral and determinants of such utilisation in 
University of Bristol 1,000 families followed prospectively through the 
Bristol Lifeways Cross-Generation cohort study
Ms Fiona O’Reilly Developing and evaluating community involvement 
Family Medicine and General Practice in primary care in North Inner City Dublin
Royal College of Surgeons in Ireland 
Dublin 2
Research Project Grants – Co-Funded in Health Services Research
Professor Gerard Bury General practice and pre-hospital emergency care:
Department of General Practice the potential impact of collaboration integration, 
Coombe Healthcare Centre new technologies and health service reform
Dublin 8
Dr Regina McQuillan An exploration of the end-of-life care needs of 
St Francis Hospice Raheny dementia patients: palliative care and geriatric 
Dublin 5 care perspectives
Professor Colm O’Morain Novel screening modalities for colorectal cancer:  
Department of Gastroenterology molecular basis of colorectal cancer from 
AMNCH prevention to cure
Tallaght, Dublin 24
Research Project Grants – General
Dr Orina Belton Cyclooxygenases in atherosclerosis: exploring the 
Department of Clinical Pharmacology cardiovascular risk of COX-2 inhibitors
Royal College of Surgeons in Ireland 
Dublin 2
Dr Andrew Bowie Elucidating the role of IRAK-2 in interleukin-1 and 
Department of Biochemistry toll-like receptor signalling
Trinity College Dublin 
Dublin 2
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Grant Holder Project Title
Dr Patrick Brennan Radiation dose optimisation for interventional 
School of Diagnostic Imaging procedures
University College Dublin
Dublin 4 
Professor Patrick Collins Membrane integrins as mediators of increased
Department of Biochemistry platelet aggregation in hyperhomocysteinaemic
Royal College of Surgeons in Ireland states
Dublin 2
Dr Richard Costello Neuro-immune interactions in allergic rhinitis
Department of Medicine 
Beaumont Hospital
Dublin 9
Professor David Croke A high-resolution map of genetic variation in the 
Department of Biochemistry Irish population
Royal College of Surgeons in Ireland 
Dublin 2
Dr Alan Dobson Pathogenicity in Aspergillus fumigatus - A 
Department of Microbiology functional genomics/proteomics approach
University College Cork
Cork
Professor Charles Dorman Analysis of switching bias in the fim genetic switch 
Department of Microbiology of Escherichia coli
Trinity College Dublin
Dublin 2
Professor Paul Engel The molecular basis of autosomal dominant retinitis 
Department of Biochemistry pigmentosa RP10: studies of IMP Dehydrogenase 1
University College Dublin
Dublin 4
Professor John Feely Prescribing indicators in primary care using a 
Department of Pharmacology and Therapeutics pharmacoepidemiological database
St James’s Hospital 
Dublin 8
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Grant Holder Project Title
Dr William M Gallagher Malignant melanoma: functional studies using DNA 
Department of Pharmacology methyltransferase inhibitors and genetic suppressor
University College Dublin element technology
Dublin 4
Dr Deirdre A Hurley Randomised controlled trial of hospital-based 
School of Physiotherapy versus community-based physiotherapy for 
Mater Misericordiae Hospital patients with low back pain: clinical outcomes and 
Dublin 7 economic analysis
Professor Dermot Kelleher Transcriptomic and proteomic approaches for the 
Department of Clinical Medicine study of the intestinal epithelial response to 
St James’s Hospital Helicobacter pylori soluble components in an ex 
Dublin 8 vivo model for duodenal ulcerogenesis
Dr Brendan Noel Kennedy In vivo models of human blindness characterised 
Department of Pharmacology by dominant cone-rod dystrophy (DCORD)
University College Dublin 
Dublin 4
Professor Marina A Lynch Analysis of the cellular events leading to the 
Department of Physiology protective effect of eicosapentaneoic acid in the brain
Trinity College Dublin
Dublin 2
Dr Justin V McCarthy Glycogen Synthase Kinase-3B and serine 
Department of Biochemistry phosphorylation: unravelling the physiological 
and Biosciences Institute functions of Presenilin-1 in Alzheimer’s disease
University College Cork
Cork
Professor Noel McElvaney Alpha1-antitrypsin (A1AT)-induced ER stress:  
Department of Medicine Intracellular stress mechanism associated with 
Beaumont Hospital Alpha 1-Antitrypsin deficiency liver disease and 
Dublin 9 development of potential therapeutic approaches
Professor Hannah McGee One-year clinical outcomes, secondary prevention 
Department of Psychology profile and health service use in a national sample 
Royal College of Surgeons in Ireland of hospital admissions for acute coronary 
Dublin 2 syndromes in Ireland
Dr Tara McMorrow Gene regulation and mechanism of epithelial- 
Department of Pharmacology mesenchymal transdifferentiation (EMT) in a 
University College Dublin cyclosporine A -induced model
Dublin 4
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Grant Holder Project Title
Dr Kevin J Mitchell The role of the transmembrane semaphorin 
Department of Genetics Sema6A in axon guidance in the mammalian brain
Trinity College Dublin
Dublin 2
Dr Tom Moore Jerky Gene: Cellular and developmental function
Department of Biochemistry
University College Cork 
Cork
Professor John Morrison Thrombin and protease activated receptors (PARs) 
Department of Obstetrics and Gynaecology and human myometrium in labour, term and 
University College Hospital preterm: expression, functional modulation and ion
Galway channel effects
Dr Paul Moynagh Defining a role for human cactin in toll-like 
Department of Pharmacology receptor signalling
University College Dublin
Blackrock, Co Dublin
Dr Evelyn Murphy Orphan nuclear receptor function in human 
Department of Biochemistry and Physiology inflammatory joint disease
Faculty of Veterinary Medicine
University College Dublin 
Dublin 4
Dr Heinz-Peter Nasheuer Physical and functional interactions of replication 
Department of Biochemistry protein A in the eukaryotic cell cycle. Analyses of 
National University of Ireland the activities of the replication protein A and their 
Galway regulation during the initiation and elongation 
process of eukaryotic DNA replication
Dr Jacqueline Nugent Developing a plastid-based, multicomponent 
Department of Biology vaccine against Helicobacter pylori
National University of Ireland
Maynooth, Co Kildare
Professor Timothy O’Brien Cytoprotection of islets after transplantation by 
Department of Medicine gene transfer of manganese superoxide dismutase
University College Hospital
Galway
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Grant Holder Project Title
Professor Eadbhard O’Callaghan A randomised control trial of carer education in 
Cluain Mhuire Service bipolar affective disorder
St Vincent’s University Hospital 
Blackrock, Co Dublin
Dr Clare O’Connor Functional analysis of differential gene expression in
Department of Medicine and Therapeutics IL-8 versus FMLP stimulated neurophils with 
University College Dublin specific reference to migratory pattern
Dublin 4
Mr Aengus S O’Marcaigh The pathophysiology of veno-occlusive disease:  
Our Lady’s Hospital for Sick Children novel therapeutic strategies
Crumlin, Dublin 12
Dr Malachy O’Rourke Investigation of blood flow through abdominal 
Department of Mechanical Engineering aortic aneurysms: towards reliable rupture prediction
University College Dublin
Dublin 4
Dr Abhay Pandit Modulation of impaired wound-healing response by
Department of Mechanical Engineering nitric oxide synthase gene transfer and the ability of
National University of Ireland a biodegradable fibrin scaffold to deliver a 
Galway therapeutic gene
Dr Margaret Worrall Characterisation of the remaining human A-clade 
Department of Biochemistry serpins
University College Dublin
Dublin 4
Research Project Grants – Interdisciplinary
Dr Sean Connolly Developing accurate seizure detection techniques 
Department of Clinical Neurophysiology in newborn babies
St Vincent’s University Hospital 
Dublin 4
Dr John Harpur Methodological issues in the use and possible 
Department of Computer Science extension of the Pragmatics Rating Scale with 
National University of Ireland Asperger adolescents
Maynooth, Co Kildare
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Grant Holder Project Title
Research Project Grants – Ireland–Northern Ireland Co-operation
Dr Clair Gardiner Investigation of the extent of KIR gene diversity and
Department of Biochemistry its role in expression
Trinity College Dublin
Dublin 2
Professor Geraldine McCarthy A study to determine the contextual indicators 
School of Nursing and Midwifery impacting on the effective proactive continence
University College Cork management in rehabilitation settings for older people
Cork
Dr Kevin McGuigan Prevention, detection and removal of pathogenic 
Department of Pharmaceutical Chemistry bacterial biofilms on medical implant surfaces
and Medical Physics 
Royal College of Surgeons in Ireland
Dublin 2
Dr Anthony Staines Risks and hazards of blood donation and 
Department of Public Health Medicine transfusion: professional and lay knowledge and 
and Epidemiology attitudes to risk in Ireland
University College Dublin 
Dublin 4
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